07/09/2022

Advanced therapy medicinal products: SMEs call for a better investment environment in Europe

07/09/2022

Factsheet – Increased regulatory efficiency; what we need for the next generation of medicine

07/09/2022

Factsheet – European Health Data Space

07/09/2022

Factsheet – A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

07/09/2022

Factsheet – A New European Innovation Agenda: biotechnology will help achieve a healthier, more sustainable, and autonomous Europe

27/07/2022

EuropaBio position on the European Health Data Space proposal

18/07/2022

EuropaBio Statement on the proposal for a Regulation on substances of human origin (SoHO)

06/07/2022

Value of Biotech

29/06/2022

EuropaBio’s Vision for Europe: Innovation, Investment, Excellence

27/06/2022

Unlocking the Promise of Gene Therapy

20/06/2022

Seizing opportunities for continued innovation, investment, and excellence in orphan medicines in Europe

25/05/2022

European Week Against Cancer 2022 – Interview with Santiago Aguirre, Market Lead Europe Oncology, Sanofi

23/05/2022

Big Changes Start Small

16/05/2022

EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive

25/04/2022

Opinion: A long journey to care, or why it’s time for an ambitious EU framework for a cross-border healthcare

04/04/2022

EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe’s innovation, investment and excellence in biotechnology

28/02/2022

EuropaBio Statement on Rare Disease Day

31/01/2022

EuropaBio becomes a partner of a new European partnership for health

22/12/2021

EuropaBio: Revision of the EU general pharmaceuticals legislation for a healthier tomorrow

13/12/2021

Interview with Ingmar Hoerr, CureVac Founder and holder of the first patents associated with mRNA

EuropaBio sat down with New Member Olon, to find out about their Plans to Expand their Biotechnology Platform.
Become a member